ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Zynerba Pharmaceuticals Inc (ZYNE) Report Updated: Jul 17, 2017 | Print This Page

Get more stock ratings by Louis Navellier

Zynerba Pharmaceuticals Inc (ZYNE)

Rating: Buy Volatility: Moderate
Total Grade: B Industry: Pharmaceuticals
Competitors: HCM,CORT,HSKA,PAHC

Stock Analysis

Rating: Monthly View

A
B
C
D
F
July August September October November December January February March April May June

Rating: Weekly View

This Week: B down no change
Last Week: B same no change
Two Weeks Ago: B up downgrade
service keys

Zynerba Pharmaceuticals Inc© quotemedia

Company Profile